CSL
Clinical Research and Development
45 Poplar Rd
Parkville
Australia
3052
Biographical Sketch:
2009-present -- Director of Clinical Development, Vaccines, CSL Limited, Parkville, VIC, Australia
2005-09 -- Director of Epidemiology, GSK Biologicals, Rixensart, Belgium
2003-05 -- Epidemic Intelligence Service Officer, Division of STD Prevention, CDC, Atlanta, GA
Responsible for clinical development and scientific strategy for influenza vaccine development (2009-present). Oversaw development of CSL's pandemic H1N1 vaccine development program and was first author of the first publication describing the immune response to a single H1N1 vaccination published in NEJM.
Author or coauthor of more than 20 publications or abstracts in peer-reviewed journals and conferences. Reviewer for more than 5 international journals.
Presented at scientific conferences worldwide.